COVID-19 in children and adolescents is associated with adverse long-term kidney outcomes, such as chronic kidney disease (CKD).

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.

(HealthDay News) — Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life (HRQL), as well as some specific symptoms such as pain, fatigue, ...

16.9 percent of the association was mediated by psychological distress; 3.0 and 3.1 percent mediated by social isolation, neuroticism.

Urodynamics investigation to identify detrusor overactivity before proceeding to invasive overactive bladder treatments do not appear helpful.

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

(HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.